friends and partners to create a special Mother’s Day for those living with Alzheimer’s disease or a related dementia. According to the Alzheimer’s Foundation of America, people should use ...

Reviewed By Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila ...

Reviewed By Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila ...

South Carolina families wondering if a loved one has Alzheimer's disease or other dementias might soon have access to a blood test that could give them some answers. A statewide consortium is also ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in ...

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now. In a paper ...

Several blood tests have been shown to accurately diagnose Alzheimer’s disease — as previously reported by Fox News Digital — but now a new test has emerged that can gauge how far it has ...

But some are donning them for an entirely different experience: to help researchers identify those most at risk of developing Alzheimer's disease. "We know that early detection of Alzheimer's ...

The next VR breakthrough could help with the early detection of a well-known neurodegenerative disease. In its current form, the diagnosis of Alzheimer’s disease requires expensive neurological ...

When it comes to the early detection of Alzheimer’s disease, a new study suggests that the nose knows. Mass General Brigham neurology researchers have created a smell test that shows promise as ...

Cassava Sciences' simufilam failed to meet co-primary endpoints in the Phase 3 REFOCUS-ALZ trial for mild-to-moderate Alzheimer's disease. Cassava will discontinue Alzheimer's drug development ...